Our Fisher Clinical Services^SM offerings are now part of the Patheon brand portfolio by Thermo Fisher Scientific. Please update your bookmark.

Post Pandemic Planning: What Will Change in Early-Phase Drug Development?

Watch as our early development experts discuss the impact of COVID-19 on sponsor/CDMO relationships moving forward, how Thermo Fisher Scientific has maintained normal CDMO operations and plans to shift to meet new needs and more.

Post Pandemic Planning: What Will Change in Early-Phase Drug Development?

Related Sites

Additional Resources